Expert consensus on a standard of activity judgment of pulmonary tuberculosis and its clinical implementation

doi:10.3969/j.issn.1000-6621.2020.04.001

Abstract

Abstract:

The epidemic situation of pulmonary tuberculosis in China is challenging. Pathogenic test of Mycobacterium tuberculosis is the “golden indicator” for the diagnosis of pulmonary tuberculosis, but the activity judgment becomes difficult when the etiological examination is negative. In addition, evaluation of activity of pulmonary tuberculosis post-treatment also encounters the pathogenic problem. This expert consensus introduces the current evaluation methods for activity judgment of pulmonary tuberculosis, and sets standards of clinical comprehensive evaluation of activity. Meanwhile, it points out the existing problems of activity judgment and its clinical implementation and discusses its future development.

Key words: Tuberculosis,pulmonary, Activity judgment, Critical pathways, Expert consensus

Clinical Research Center for Infectious Disease, the Third People’s Hospital of Shenzhen, Editorial Board of Chinese Journal of Antituberculosis National. Expert consensus on a standard of activity judgment of pulmonary tuberculosis and its clinical implementation[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 301-307. doi: 10.3969/j.issn.1000-6621.2020.04.001

Figures/Tables 2

References 47

[1]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[2]	张慧, 刘剑君 . 建国70年来结核病防治工作要览与展望. 中国防痨杂志, 2019,41(9):913-916.
[3]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
[4]	中华人民共和国国务院办公厅. “十三五”全国结核病防治规划. 国办发〔2017〕16号. 2017 -02-07.
[5]	周新华, 陈步东, 吕岩 , 等. 非活动性肺结核的影像学评价. 中国防痨杂志, 2018,40(3):251-254.
[6]	Linguissi LS, Vouvoungui CJ, Poulain P , et al. Diagnosis of smear-negative pulmonary tuberculosis based on clinical signs in the Republic of Congo. BMC Res Notes, 2015,8:804.
[7]	Goletti D, Lindestam Arlehamn CS, Scriba TJ , et al. Can we predict tuberculosis cure? What tools are available? Eur Respir J, 2018, 52(5). pii: 1801089.
[8]	赵鸿鹏, 路希维 . 影像学检查在肺结核诊治中的应用现状与展望. 结核病与肺部健康杂志, 2019,8(1):5-8.
[9]	Im JG, Itoh H, Shim YS , et al. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy. Radiology, 1993,186(3):653-660.
[10]	Skoura E, Zumla A, Bomanji J . Imaging in tuberculosis. Int J Infect Dis, 2015,32:87-93.
[11]	Malherbe ST, Shenai S, Ronacher K , et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med, 2016,22(10):1094-1100.
[12]	Ko Y, Lee HY, Park YB , et al. Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis. PLoS One, 2018,13(8):e0201748.
[13]	Long R, Maycher B, Dhar A , et al. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest, 1998,113(4):933-943.
[14]	Bhalla AS, Goyal A, Guleria R , et al. Chest tuberculosis: Radiological review and imaging recommendations. Indian J Radiol Imaging, 2015,25(3):213-225.
[15]	贺伟, 李成海, 谢汝明 , 等. 活动性肺结核抗结核治疗后的HRCT影像动态分析及残余病变的临床意义. 中华实验和临床感染病杂志(电子版), 2015,9(6):38-42.
[16]	Lewinsohn DM, Leonard MK LoBue PA, , et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis, 2017,64(2):111-115.
[17]	Nakajima T, Yasufuku K, Fujiwara T , et al. Recent advances in endobronchial ultrasound-guided transbronchial needle aspiration. Respir Investig, 2016,54(4):230-236.
[18]	中华医学会. 临床诊疗指南:结核病分册. 北京: 人民卫生出版社, 2005.
[19]	Lyon SM, Rossman MD. . Pulmonary Tuberculosis Microbiol Spectr, 2017,5(1). doi: 10.1128/microbiolspec.TNMI7-0032-2016.
[20]	Pasipanodya JG, Miller TL, Vecino M , et al. Pulmonary impairment after tuberculosis. Chest, 2007,131(6):1817-1824.
[21]	张宏英, 陈力舟, 林敏 , 等. 痰与支气管肺泡灌洗液结核分枝杆菌FQ-PCR检测对涂阴肺结核诊断价值的比较. 中国防痨杂志, 2011,33(12):806-809.
[22]	Friedrich SO, Rachow A, Saathoff E , et al. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med, 2013,1(6):462-470.
[23]	崔振玲, 沙巍, 黄晓辰 , 等. RNA恒温扩增技术快速检测痰标本中结核分枝杆菌的研究. 中华结核和呼吸杂志, 2011,34(12):894-897.
[24]	Honeyborne I, Mtafya B, Phillips PP , et al. The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment. J Clin Microbiol, 2014,52(8):3064-3067.
[25]	Tenforde MW, Gupte N, Dowdy DW , et al. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One, 2015,10(2):e0117424.
[26]	Rathish D, Siribaddana S . Tuberculosis induced autoimmune haemolytic anaemia: a systematic review to find out common clinical presentations, investigation findings and the treatment options. Allergy Asthma Clin Immunol, 2018,14:11.
[27]	Carrara S, Vincenti D, Petrosillo N , et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis, 2004,38(5):754-756.
[28]	Aiken AM, Hill PC, Fox A , et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis, 2006,6:66.
[29]	宋其生, 陈秀琴, 赵琴 , 等. 结核菌素纯蛋白衍生物试验净增值与γ-干扰素释放试验在结核病群体感染中的诊断价值. 中华结核和呼吸杂志, 2012,35(9):669-672.
[30]	Wang F, Yu J, Zhou Y , et al. The use of TB-specific antigen/phytohemagglutinin ratio for diagnosis and treatment monitoring of extrapulmonary tuberculosis. Front Immunol, 2018,9:1047.
[31]	Ahmed MIM, Ntinginya NE, Kibiki G , et al. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy. Front Immunol, 2018,9:2247.
[32]	宋其生, 路希伟, 王镇山 , 等. CT在肺结核疗效判断与随访观察中的应用评价. 国际呼吸杂志, 2008,28(24):1482-1486.
[33]	路希伟, 伍建林, 张国庆 , 等. 涂阴、涂阳活动性肺结核CT征象的对照研究. 中国医学影像技术, 2007,23(9):1337-1341.
[34]	路希伟, 朱丽君, 权占盛 , 等. 31例活动性肺结核治疗前及治愈后的CT征象分析. 中国防痨杂志, 2006,28(5):295-298.
[35]	谈高, 柳学国, 张庆文 , 等. 高分辨率CT诊断早期和(或)活动性肺结核. 中华放射学杂志, 2003,37(7):604-608.
[36]	De Backer AI, Mortelé KJ, Van Den Heuvel E , et al. Tuberculous adenitis: comparison of CT and MRI findings with histopathological features. Eur Radiol, 2007,17(4):1111-1117.
[37]	Zeng J, Liu Z, Shen G , et al. MRI evaluation of pulmonary lesions and lung tissue changes induced by tuberculosis. Int J Infect Dis, 2019,82:138-146.
[38]	Jeong YJ, Paeng JC, Nam HY , et al. ¹⁸F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis . J Korean Med Sci, 2014,29(3):386-391.
[39]	Hnizdo E, Singh T, Churchyard G . Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax, 2000,55(1):32-38.
[40]	Cadena AM, Fortune SM, Flynn JL . Heterogeneity in tuberculosis. Nat Rev Immunol, 2017,17(11):691-702.
[41]	中华医学会结核病学分会, 结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017,40(6):419-425.
[42]	Rindi L, Ali G, Fabiani B , et al. Detection of Mycobacterium tuberculosis from paraffin-embedded tissues by GeneXpert MTB/RIF. Tuberculosis (Edinb), 2017,106:53-55.
[43]	罗春英, 王建东, 王璇 , 等. 荧光定量聚合酶链反应检测石蜡包埋组织结核杆菌的应用价值. 中华病理学杂志, 2012,41(8):562-563.
[44]	Méchaï F, Fock-Yee C, Bouvry D , et al. Pulmonary tuberculosis: Radiological evolution of broncho-pulmonary lesions at the end of treatment. Rev Mal Respir, 2019,36(1):22-30.
[45]	Nahid P, Mase SR, Migliori GB , et al. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med, 2019,200(10):e93-142.
[46]	Chakaya J, Kirenga B, Getahun H . Long Term Complications After Completion of Pulmonary Tuberculosis Treatment: A Quest For a Public Health Approach. J Clin Tuberc Other Mycobacterial Diseases, 2016,3:10-12.
[47]	Nam KJ, Jeong YJ, Kim YD , et al. Chronic destructive pulmonary tuberculosis: assessment of disease activity by computed tomography. Acta Radiol, 2012,53(9):1014-1019.